The Zirmon Series is indicated for use as a substructure for porcelain fused ceramic fixed dental restorations; namely crown, bridges, inlays, and onlays.

Device Description

The Zirmon Series is zirconia-based ceram provided in shapes of square and circle used to manufacture cores of all ceramic crowns, and is classified into ISO6872 Type 2 Class 1. This dental porcelain for cutting process is provided by shaping and semi-sintering zirconia powder and is used to manufacture ceramic restoration with cutting process by dental MAD/MAM, computer-assisted design system, or manufacturing units, CAD/CAM system.

AI/ML Overview

The provided text describes the 510(k) summary for the "Zirmon Series" dental frame material, indicating its substantial equivalence to a predicate device. However, this document does not contain information about a study that assesses a device's performance against acceptance criteria in the context of AI/ML or diagnostic accuracy, nor does it involve human readers, ground truth establishment, or multi-reader studies.

The "Performance Data (Non-Clinical)" section refers to bench testing based on international standards for materials rather than clinical performance or diagnostic accuracy. Therefore, many of the requested details cannot be extracted from this specific document.

Below is an attempt to address the points based only on the provided text, with clear indications where the information is not available.

1. Table of Acceptance Criteria and Reported Device Performance

Acceptance Criterion (Standard Reference)	Reported Device Performance
ISO 6872 - Package	Met preset test criteria
ISO 6872 - Uniformity	Met preset test criteria
ISO 6872 - Freedom from extraneous materials	Met preset test criteria
ISO 6872 - Radioactivity	Met preset test criteria
ISO 6872 - Chemical solubility	Met preset test criteria
ISO 6872 - Flexural strength	Met preset test criteria
ISO 6872 - Linear Thermal Expansion Coefficient	Met preset test criteria
ISO 13356 - Monoclinic Phase Rate	Met preset test criteria
ISO 13356 - Flexural strength	Met preset test criteria
ISO 10993-5 - Cytotoxicity	Met preset test criteria
ISO 10993-11 - Acute systemic toxicity	Met preset test criteria
ISO 10993-10 - Oral Mucosa Irritation & Sensitization	Met preset test criteria
Other bench testing - Appearance	"Appearance, dimension and weight spec test" - Met preset test criteria
Other bench testing - Dimension	"Appearance, dimension and weight spec test" - Met preset test criteria
Other bench testing - Weight	"Appearance, dimension and weight spec test" - Met preset test criteria

2. Sample size used for the test set and the data provenance

Sample size: Not specified. The document refers to "the following properties were tested" but does not give sample sizes for these material property tests.
Data provenance: Not specified. The testing was non-clinical (bench testing) and likely performed by the manufacturer (KUWOTECH Co., Ltd.) in the Republic of Korea.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

This information is not applicable and not available. The testing involved material properties against international standards, not diagnostic accuracy requiring expert interpretation.

4. Adjudication method for the test set

Not applicable and not available. The testing involved material properties, not an assessment requiring adjudication of diagnostic findings.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable and not available. This is a non-clinical submission for a dental material, not an AI/ML or diagnostic imaging device.

6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done

Not applicable and not available. This is not an algorithm-based device.

7. The type of ground truth used

The "ground truth" for the material tests was defined by the requirements and measurement methodologies specified in the cited ISO standards (e.g., specific thresholds for flexural strength, chemical solubility limits, etc.). It is not based on expert consensus, pathology, or outcomes data in the clinical sense.

8. The sample size for the training set

Not applicable and not available. This device is a material, not an AI/ML model that requires a training set.

9. How the ground truth for the training set was established

Not applicable and not available. (Same as point 8).

Summary

{0}------------------------------------------------

510(k) Summary

JUL 2 6 2013

This summary of 510(k)-safety and effectiveness information is being submitted in accordance with requirements of 21 CFR Part 807.92.

05/22/2013 Date: Date:

1. Submitter:

Name:	KUWOTECH Co., Ltd.50 Cheomdan venture so-ro, 37 beon-gil,Buk-gu, Gwang-ju, Republic of KoreaTel: +82-62-971-0182Fax: +82-62-971-0185
Contact:

2. Submission Correspondent:

Priscilla Chung LK Consulting Group USA, Inc. 1515 E. Katella Ave. Unit 2115, Anaheim, CA 92805 Fax: 714-409-3357 Phone: 714-202-5789 Email: juhee.c@lkconsultinggroup.com

3. Device:

Proprietary Name:	Zirmon Series
Common Name:	Dental Frame Material for Dental Prosthesis
Classification Name:	Porcelain Powder for Clinical Use
Classification:	Class II, 21 CFR 872.6660
Classification Product Code:	EIH

4. Predicate Device:

Vita In-Ceram YZ® Cubes for Cerec® (K022996) by VITA Zahnfabrik GmbH & Co. KG

5. Device Description:

{1}------------------------------------------------

dental MAD/MAM, computer-assisted design system, or manufacturing units, CAD/CAM system.

6. Intended Use:

The Zirmon Series is indicated for use as a substructure for porcelain fused ceramic fixed dental restorations; namely crown, bridges, inlays, and onlays.

7. Performance Data(Non-Clinical):

The following properties were tested based on the referenced standards. All the test results met the preset test criteria.

· ISO 6872 - Package, Uniformity, Freedom from extraneous materials, Radioactivity, Chemical solubility, Flexural strength, and Linear Thermal Expansion Coefficient

ISO 13356 Monoclinic Phase Rate and Flexural strength
· ISO 10993-5 Cytotoxicity
ISO 10993-11 Acute systemic toxicity
ISO 10993-10 Oral Mucosa Irritation & Sensitization
· Other bench testing Appearance, dimension and weight spec test

8. Substantial Equivalence

The Zirmon Series is substantially equivalent to the Vita In-Ceram YZ® Cubes for Cerec® (K022996). They share the same material and similar physical / chemical properties. The main difference is the dimensions and the subject device offers more shapes; however, the differences do not raise new safety or performance issues. The performance testing results presented in the 510K supports that the Zirmon Series is substantially equivalent in safety and effectiveness to the predicate device.

9. Conclusion:

Based on the testing results. KUWOTECH Co. Ltd concludes that the Zirmon Series is substantially equivalent in safety and effectiveness to the predicate device.

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services USA. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" written around the perimeter. Inside the circle is an abstract image of an eagle.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

July 26. 2013

KUWOTECH Co., Ltd. C/O Ms. Priscilla Chung Official Correspondent LK Consulting Group USA, Inc. 1515 East Katella Avenue, Unit 2115 Anaheim. CA 92805

Re: K131117

Trade/Device Name: Zirmon Series Regulation Number: 21 CFR 872.6660 Regulation Name: Porcelain Powder for Clinical Use Regulatory Class: II Product Code: Ell-l Dated: May 23, 2013 Received: May 28. 2013

Dear Ms. Chung:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA). it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{3}------------------------------------------------

Page 2 - Ms. Chung:

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours,

Mary S. Runner -S

Kwame Ulmer M.S. Acting Division Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Indications for Use

510(k) Number (if known): _(13 || 17

Device Name: Zirmon Series

Indications for Use:

The Zirmon Series is indicated for use as a substructure for porcelain fused ceramic fixed dental restorations; namely crown, bridges, inlays, and onlays.

Prescription Use V (Per 21 CFR 801 Subpart D)

AND

Over-The Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Sheena A. Green -S 2013.07.30 11:51:56 -04'00'

for M. Susan Runner, DDS, MA

(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number:	K131117

Regulation Number and Section

§ 872.6660 Porcelain powder for clinical use.

(a)
Identification. Porcelain powder for clinical use is a device consisting of a mixture of kaolin, felspar, quartz, or other substances intended for use in the production of artificial teeth in fixed or removable dentures, of jacket crowns, facings, and veneers. The device is used in prosthetic dentistry by heating the powder mixture to a high temperature in an oven to produce a hard prosthesis with a glass-like finish.(b)
Classification. Class II.